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The Workshop on Animal Botulism in Europe
Hanna Skarin, Annica Tevell A˚berg, Ce´dric Woudstra, Trine Hansen, Charlotta Lo¨fstro¨m, Miriam Koene,
Luca Bano, Mikael Hedeland, Fabrizio Anniballi, Dario De Medici, and Eva Olsson Engvall
A workshop on animal botulism was held in Uppsala, Sweden, in June 2012. Its purpose was to explore the current
status of the disease in Europe by gathering the European experts in animal botulism and to raise awareness of the
disease among veterinarians and others involved in biopreparedness. Animal botulism is underreported and under-
diagnosed, but an increasing number of reports, as well as the information gathered from this workshop, show that it is
an emerging problem in Europe. The workshop was divided into 4 sessions: animal botulism in Europe, the bacteria
behind the disease, detection and diagnostics, and European collaboration and surveillance. An electronic survey was
conducted before the workshop to identify the 3 most needed discussion points, which were: prevention, preparedness
and outbreak response; detection and diagnostics; and European collaboration and surveillance. The main conclusions
drawn from these discussions were that there is an urgent need to replace the mouse bioassay for botulinum toxin
detection with an in vitro test and that there is a need for a European network to function as a reference laboratory,
which could also organize a European supply of botulinum antitoxin and vaccines. The foundation of such a network
was discussed, and the proposals are presented here along with the outcome of discussions and a summary of the
workshop itself.
On June 7 and 8, 2012, an animal botulism work-shop was held in Uppsala, Sweden. The workshop
was hosted by the Swedish National Veterinary Institute
and organized through the European Union (EU)–funded
project AniBioThreat.
Background
Botulism is a paralytic disease caused by botulinum
neurotoxins, which are produced mainly by the bacterial
species Clostridium botulinum. These neurotoxins affect
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animals as well as humans worldwide and are included in
the Centers for Disease Control and Prevention (CDC) list
of potential biothreat agents.1 C. botulinum is a strictly
anaerobic spore-forming bacterium found in soil around
the world.2 It produces neurotoxin in environments that
permit germination of the spores, such as canned food and
silage.3,4 The accessibility and dissemination potential of
C. botulinum spores in combination with the high health
impact on both humans and animals also make the bacte-
rium a biological risk agent.1 Botulism is usually caused by
ingestion of preformed toxin, but there are also cases caused
by toxicoinfection. The toxicoinfectious form, which is
mainly connected with wound botulism and botulism in
young animals, infants, and birds, is caused by botulinum
neurotoxins produced in situ after germination of spores in
wounds or the intestine.
Strains belonging to the species C. botulinum can be di-
vided into 4 physiological groups, I through IV.5 Groups I
and II cause both human and animal botulism, whereas group
III is mainly connected with animal botulism. Although
considered a zoonotic disease, human botulism attracts more
attention than animal botulism, which has resulted in stricter
national and international regulations and control measures
against human botulism compared to animal botulism. For
example, thanks to international regulations and networks,
there are surveillance data for human botulism cases, whereas
the status of animal botulism is vague. Considering the eco-
nomic impact and the large number of animals that die
during an animal botulism outbreak, it is important to focus
also on animal botulism. And in terms of biopreparedness, it
is essential to consider both human and animal health.
Purpose and Outline of the Workshop
The purpose of the workshop was to explore the current
status of animal botulism in Europe and to discuss important
issues regarding laboratory work and diagnostics, control
measures, and biopreparedness by gathering the European
experts in the area of animal botulism. Another important
aspect of this workshop was to take the opportunity to share
the information from AniBioThreat on animal botulism
with European veterinarians and scientists working on ani-
mal botulism outside the project. The participants were
veterinarians and scientists from 11 European countries:
Belgium, Denmark, Finland, Germany, Great Britain,
France, Italy, Norway, Spain, Sweden, and the Netherlands;
1 invited keynote speaker was from Japan. Abstracts de-
scribing the situation of animal botulism in the past decade
were collected from participating countries as a complement
to the workshop.6 An electronic survey (QuestBack) was
conducted before the workshop to collect information about
key issues and to identify relevant discussion points.
The workshop was divided into 4 sessions. The first ses-
sion, Animal Botulism in Europe, aimed to explore the
current status of the disease in Europe and to discuss prac-
tical measures taken in European countries during botulism
outbreaks. Sessions 2 and 3, The Bacteria Behind the Disease
and Detection and Diagnostics, aimed to inform the par-
ticipants about genomic characterizations, epidemiology,
and detection method developments that were performed in
the AniBioThreat project. A further objective was to im-
plement those methods at other laboratories in Europe by
providing demonstrations of methods. These 2 sessions also
included discussions about laboratory work and future di-
agnostic needs. Session 4, European Collaboration and
Surveillance, was intended to highlight EU projects that
focus on botulism as examples of European collaboration
and to discuss implementation of control measures and
surveillance of animal botulism at a European level.
This meeting report provides synopses of the sessions,
including key information given at presentations and col-
lected from the abstract book and survey, and the outcomes
of discussions in the form conclusions and proposals for
future work on animal botulism in Europe. The presenters
are listed at the end of this article.
Opening of the Workshop
The workshop was opened by Hanna Skarin and Jeffrey
Skiby, followed by a presentation about the AniBioThreat
project by coordinator Rickard Knutsson. Dr. Knutsson
presented the project background and introduced the core
issue of the project, which is to bridge the fields of research,
security, and safety in order to improve the EU’s capacity to
counter biological animal biothreats. Viveca Ba˚verud then
introduced the topic of animal botulism from a veterinary
perspective. She described the classical signs of flaccid pa-
ralysis caused by the botulinum neurotoxin and the variety
of symptoms in different animal species. Keynote speaker
Shunji Kozaki from Osaka Prefecture University in Japan
was invited to present research regarding the organization
and biological properties of the botulinum neurotoxins
produced by C. botulinum group III.
Synopsis of Animal Botulism in Europe
Session
Current Status of the Disease
in Europe
Presentations in this session covered the current status of
the disease in Norway (Simon Hardy), Spain (Ibone Anza
Gomez), Italy (Luca Bano), France (Rozenn Souillard and
Caroline Le Mare´chal), Germany (Helge Bo¨hnel, Frank
Gessler, and Birgit Schwagerick), and Sweden (Hanna
Skarin and Gunilla Blomqvist). The focus in all presenta-
tions, as well as in the abstracts, which described the status
also in Belgium, Denmark, the Netherlands, and the
United Kingdom, was on botulism in cattle or avian
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species. Botulism in dogs, horses, minks, and small rumi-
nants was also mentioned. So-called visceral or chronic
botulism was reported from Germany and Denmark. This
condition affecting cattle is considered to be caused by a
proliferation of C. botulinum group III strains in the gut
(toxicoinfection). Although the use of botulinum vaccines
was reported to have beneficial effect in some herds with
visceral botulism, the existence of this specific clinical form
of botulism is still controversial.6
Difficulties in evaluating the disease situation and gath-
ering epidemiologic data were discussed. Several reasons
were offered, including the limited knowledge of the disease
among veterinary practitioners, the lack of laboratories
authorized to perform the reference method for botulism
diagnostics (the mouse bioassay), and farmers’ concerns
about diagnosing the disease because of the trade restric-
tions that result if botulism is confirmed. It was concluded
that one of the most important factors leading to an un-
derestimation of the disease is that the diagnosis of botulism
often is made by veterinary practitioners and based solely
on clinical signs without laboratory confirmation (Figure
1). Furthermore, the lack of therapeutic (antitoxins) or
prophylactic (vaccines) tools needed to combat animal
botulism outbreaks in many European countries discour-
ages requests for laboratory confirmation. As a conse-
quence, many cases are not reported, since the laboratory
usually reports confirmed botulism cases to national au-
thorities. Moreover, animal botulism is not a notifiable
disease in most European countries (unlike human botu-
lism), which also contributes to cases never being reported.
In spite of the fact that animal botulism is an under-
diagnosed and underreported disease, it is an emerging
problem in several European countries. An increase of an-
imal botulism cases during the past decade was reported at
the workshop, in the abstracts,6 and in other reports.7-10
Prevention, Preparedness,
and Outbreak Response
To summarize key information from the presentations in
this session regarding prevention, preparedness, and out-
break response:
 Spores of C. botulinum are not frequently or constantly
present in Scandinavian poultry holdings, even at times
when outbreaks have occurred. Therefore, it is likely that
an outbreak is preceded by a recent introduction of
spores to the flock.
 Identified sources of C. botulinum spores for poultry and
cattle are feed, rice hulls used as a litter component,
carcasses, rodents, soil, and hay packaged in plastic.
 Identified risk factors for botulism in poultry are a low
biosafety barrier, no acidification or chlorination of
drinking water, and no pest control.
 Quick removal of carcasses during outbreaks is effective
in slowing down the rate of the outbreak, both in wild
and domestic avian species.
 Administration of ampicillin in drinking water is an ef-
fective method of decreasing the mortality rate in poultry
outbreaks. However, clinical signs of botulism may
Figure 1. Laboratory Confirmation of Animal Botulism. The figures show the results from question 2 in the survey. The results are
shown as a percentage of the 27 answers from survey participants, who are from Belgium, Denmark, Finland, Germany, Great Britain,
France, Italy, Norway, Spain, Sweden, and the Netherlands. Fewer than 50% of the participants in the survey responded that
laboratory analyses are performed on a routine basis to confirm botulism. This result indicates that there are many cases of botulism in
animals that will never be reported. Color images available online at www.liebertpub.com/bsp
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reappear before slaughter when animals are not allowed
to be treated with antibiotics.
The matter of asymptomatic infection was also discussed.
It is known that poultry can carry spores and toxin without
showing any symptoms.11,12 Such carriers pose a risk to other
animals, especially if poultry carcasses or manure are used for
fertilizing pastures or grass that will be used for silage. If
recommended practices were followed, the spread of spores
from chickens could be prevented.13 What is less well known
is how frequently other farm and wild animals act as carriers
of spores of C. botulinum. This should be further explored as
it could be another risk factor for botulism outbreaks.
It was concluded that there is a need for guidelines and
control measures for handling a botulism outbreak—for
example, regarding incineration of dead animals, disinfection
of farms, and dealing with manure from the farm. There is
also a need for better animal feed quality management.
Toxoid botulinum vaccines are commercially available for
use in mink (C. botulinum type C toxin), cattle and sheep
(both C. botulinum type C and type D toxin), and horses
(C. botulinum type B toxin). However, those vaccines, except
for some produced and used at the national level, are im-
ported from the US, South Africa, and Australia. The results
from the survey showed that mink is the only animal species
routinely vaccinated against botulinum toxin in Europe.
Cattle are sometimes vaccinated in outbreak situations, and
horses occasionally are vaccinated during outbreaks or if they
are kept in pastures in areas with a history of botulism. In
Italy, pheasants are sometimes vaccinated with vaccine in-
tended for mink. Vaccination of cattle was considered to be
effective in outbreak situations if administrated quickly.
Unfortunately, vaccine stocks for cattle are not available in all
European countries, and it may be time-consuming to receive
import permits for vaccines. The availability of antiserum and
vaccines in Europe was discussed, and it was concluded that
there is a need for a European antitoxin bank with sera against
the different toxin types, as well as a centralized European
commercial vaccine production facility. The fact that most of
the botulinum vaccines used in Europe are imported makes
European livestock vulnerable in a crisis situation, whether
there is a biothreat against animals or an increase in outbreaks
due to natural causes.
Synopsis of the Session C. botulinum:
The Bacteria Behind the Disease
Keynote speaker Ian Poxton from the University of Edin-
burgh in Scotland introduced the complex question of
whether C. botulinum group III and C. novyi should belong
to the same species. He also talked about equine grass
sickness, which causes malfunctions of the autonomic
nervous system of horses. Little is known about the etiology
of the disease, but it is thought to be caused by C. botuli-
num group III or C. novyi.14 The possibility that it could be
due to a toxicoinfection in a way similar to that proposed to
be the cause of visceral botulism was discussed. It was also
hypothesized that these types of diseases may be caused by
toxicoinfection of botulinum strains that have lost the
ability to produce botulinum neurotoxin.
In their presentation, Bo Segerman and Hanna Skarin
talked about the genetic diversity within the pan-genome of
C. novyi and group III of C. botulinum. They concluded
that the pathogenicity of strains is more dependent on the
plasmids they contain than to which genotypic group they
belong. C. botulinum group III harbors many plasmids and
prophages containing several toxin genes in addition to the
botulinum neurotoxin,15 which supports the hypothesis
that a strain that has lost the ability to produce botulinum
neurotoxin can still be pathogenic.
Laboratory Work on C. botulinum
Group III
The issue of strains losing the bacteriophage during preen-
richment was discussed, since this leads to a negative result by
current diagnostic detection methods, which are based on
confirmation of the neurotoxin or the neurotoxin gene. It
was experienced that some strains lose the bacteriophage
more easily than others, but this must be further explored. A
chromosomal marker can be included in the diagnostic PCR
assays in order to detect the bacterium, but it is not always
useful to detect a toxin-negative strain since it does not
provide supportive data for confirmation of the disease.
Another issue that was discussed at the meeting was that of
strain isolation from clinical or environmental samples.
Some laboratories successfully isolate strains by direct culti-
vation on blood or egg agar plates and by recognition of the
colony morphology. One laboratory used an im-
munomagnetic separation technique and considered that to
be helpful. However, due to several factors such as poor
growth on agar plates and being a strict anaerobe, it was
concluded thatC. botulinum is a difficult organism to isolate.
It was concluded from the survey that most participating
institutes perform laboratory work on C. botulinum group
III strains in BSL-2 laboratories, although a few work in
BSL-3 laboratories.




Keynote speaker Miia Lindstro¨m from the University of
Helsinki in Finland gave an introduction to botulism di-
agnostics, including the different steps in the mouse bio-
assay, which is used to diagnose botulism, and pointed out
the drawbacks of the method.
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Two different alternative methods for botulinum toxin
detection were presented by Jan Langeveld and Annica
Tevell A˚berg. Both alternative methods demonstrate toxin
activity through cleavage of synthetic peptides, which mi-
mic the proteins involved in the SNARE complex where the
toxins act in vivo. Jan Langeveld presented an assay that
combines botulinum neurotoxin capture on synaptosomes
and immunochemical analysis of the peptide cleavage
products.16 Annica Tevell A˚berg presented an endopepti-
dase method that uses an antibody capture of the botuli-
num neurotoxin followed by determination of its activity
and differentiation between different serotypes by mass
spectrometric detection of the cleaved peptides. The latter
assay, called Endopep-MS, was developed at CDC.17-19
Both methods are currently being optimized and validated
with the goal of replacing the mouse bioassay.
The mouse bioassay is still considered to be the gold
standard method for laboratories to confirm botulism and is
thus by far still the most common method used by European
laboratories, as reported in the survey conducted in connec-
tion with the workshop (Figure 2). The urgency of replacing
the mouse bioassay with an in vitro test was raised, both for
ethical reasons and because several laboratories have experi-
enced increased difficulties in getting permission to continue
performing the mouse bioassay. While developing and vali-
dating replacement methods, it is important to decrease the
number of mice used, and it was suggested that the mouse
bioassay should be used only to confirm active botulinum
toxin, but that serotype should be determined by alternative
methods. It was agreed that it is important to have a method
that detects active toxin and all serotypes of toxins with equal
sensitivity. From a clinical viewpoint, fast detection is also
important since administration of antitoxin has to be done
within the first 24 hours to be effective.
DNA-based Detection
Joakim A˚gren presented the software Gegenees (www.
gegenees.com), which can be used for comparative analyses
of whole genome sequence data and to define unique ge-
nomic signatures for specific target groups.20 The program
is useful when designing specific detection methods. Cedric
Woudstra presented the GeneDisc technology and the 2
prototypes for detection of botulinum neurotoxin gene of
type C, D, and mosaic types C/D and D/C toxin.21 The
Gegenees program and GeneDisc technology were also
demonstrated for participants to get a hands-on experience
from using the different methods. It was agreed that gene
detection methods are suitable for detection of C. botuli-
num in research settings and for screening of samples in
order to minimize the use of the mouse bioassay.
Synopsis of the European Collaboration
and Surveillance Session
The EU-financed AniBioThreat project is a good example
of European collaboration regarding animal botulism, and
Figure 2. Laboratory Confirmation of Animal Botulism. The figure shows the results from question 3 in the survey. The results are
shown as a percentage of the 27 answers from survey participants, who are from Belgium, Denmark, Finland, Germany, Great Britain,
France, Italy, Norway, Spain, Sweden, and the Netherlands. The mouse bioassay is still the gold standard method in botulism
diagnosis, which is reflected in the answers to question 3. The other toxin detection method that was mentioned in the comments was
the enzyme-linked immunosorbent assay (ELISA). PCR-based methods are also used to some extent in European laboratories for
confirmation of botulism. Color images available online at www.liebertpub.com/bsp
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the work performed so far was summarized by task leader
Dario De Medici. The overall objective was to improve
methods for detection of C. botulinum in animal, feed,
environmental, and food samples. Several detection meth-
ods, PCR based and toxin based, have been developed in
the project, and methods will be validated and established
by performing ring trials in the partner institutes, all in
order to increase the EU’s capacity to respond to animal
bioterrorism threats. Andreas Rummel presented the EU
project Establishment of Quality Assurances for the De-
tection of Biological Toxins of Potential Bioterrorism Risk
(EQuaTox), which started in 2012 (http://equatox.net).
The project aims to harmonize and standardize detection
methods for biological toxins, such as botulinum toxin.
Most participants in the survey believed that there is a need
for a European network to function as a reference laboratory
for botulism. There is currently no World Organization for
Animal Health (OIE) reference laboratory or collaborating
center for animal botulism and, to our knowledge, no other
reference laboratory at the European or international level
focusing on animal botulism. The structure of such a refer-
ence lab was further discussed. As botulism is a disease that
can affect both humans and animals, it was decided to pro-
pose a structure that covers both food and animal safety.
Instead of centralizing the duties of a reference laboratory in 1
institute, it was proposed to initiate a reference laboratory
network consisting of several institutes. The purpose of such a
network should be to standardize and harmonize methods,
by, for example, offering reference material, and to provide
expertise and diagnostic facilities. Laboratories that cannot
perform the required tests should be able to send their
samples to the network laboratories for testing.
The need for a surveillance system for animal botulism
was also discussed. It was suggested that botulism should
be added to the OIE listed diseases (http://www.oie.int/
animal-health-in-the-world/oie-listed-diseases-2012/), which
means that it would be regarded as a notifiable disease
worldwide. Botulism is included in the B list of zoonoses
and zoonotic agents to be monitored according to the ep-
idemiologic situation as stated in the EU Zoonoses Di-
rective,22 and EU member states can therefore decide to
establish a surveillance system if required. According to the
same directive, foodborne outbreaks in humans must be
reported. The European Center of Disease Prevention and
Control (ECDC) identifies and communicates threats to
human health in terms of infectious diseases by collecting
surveillance data from member states and compiling it into
annual epidemiologic reports. Regarding botulism, these
reports take into account only confirmed human botulism
cases, since that is currently the only accessible surveillance
data in the EU. When it comes to botulism in animals, it is
up to the European Commission together with member
states to decide if surveillance will be organized across the
EU. However, scientific and technical support for orga-
nizing a surveillance program can be provided by the Eu-
ropean Food Safety Authority (EFSA).
At the meeting it was concluded that in order to be able to
perform surveillance of animal botulism cases, there has to be
a reporting system established in each country, along with
better and more efficient diagnostic tools; otherwise, the dis-
ease will continue to be underdiagnosed and underreported.
Concluding Remarks
How well prepared are we for future threats of botulism?
Thanks to national and international research projects in
the field, there are now fast and accurate diagnostic meth-
ods being established, and awareness is increasing in Eur-
ope. The AniBioThreat project is an excellent example of a
project spanning country boundaries and thereby increas-
ing communication and awareness in Europe. The aim is to
continue the scientific collaboration between partners after
the AniBioThreat project ends.
Different needs that have to be addressed to increase
biopreparedness in Europe were defined at the workshop.
Examples of such needs are a centralized commercial stock
of botulinum antitoxins and vaccines, implementation of
efficient toxin detection tools in European laboratories, and
a surveillance system for animal botulism cases. It is also
necessary to increase awareness among veterinarians work-
ing in the field with clinical cases and to provide guidelines
for handling botulism outbreaks. Finally, there are indica-
tions that animal botulism is an emerging disease in Europe
and should therefore be getting more attention from both a
human and an animal health perspective.
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